Temperature excursions above 77 degrees Fahrenheit cause accelerated degradation of the peptide
Some patients have reported using compounded versions of tirzepatide at lower concentrations to facilitate microdosing, though the FDA has issued warnings about the risks of compounded GLP-1 receptor agonists, including concerns about quality, potency, dosing errors, and different salt forms
Adjustments can depend on a variety of factors, including the patients response to the medication and the presence of side effects
BPC-157 brings a deep tendon, gastrointestinal, and angiogenesis record, and TB-500 brings a distinct actin-regulation and wound-closure record, which is what makes the pairing scientifically interesting
Last reviewed: July 7, 2026 Last updated: July 7, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations